|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 27.00 SAR | -1.46% |
|
+0.07% | -3.43% |
| 12-28 | Al Hammadi Bags Antitrust Nod for Purchase of 40% Stake in Wareed Medical | MT |
| 12-28 | Al Hammadi gets Saudi GAC's NOC to acquire 40% of Wareed Medical Co | RE |
| Capitalization | 4.38B 1.17B 1B 934M 869M 1.62B 106B 1.75B 10.74B 4.22B 50.48B 4.29B 185B | P/E ratio 2025 * |
17.3x | P/E ratio 2026 * | 14.4x |
|---|---|---|---|---|---|
| Enterprise value | 4.38B 1.17B 1B 934M 869M 1.62B 106B 1.75B 10.74B 4.22B 50.48B 4.29B 185B | EV / Sales 2025 * |
3.6x | EV / Sales 2026 * | 3.19x |
| Free-Float |
75.96% | Yield 2025 * |
3.76% | Yield 2026 * | 4.79% |
| 1 day | -1.39% | ||
| 1 week | +0.07% | ||
| Current month | -3.43% | ||
| 1 month | -4.66% | ||
| 3 months | -21.54% | ||
| 6 months | -27.13% | ||
| Current year | -3.43% |
| 1 week | 26.98 |  | 27.78 |
| 1 month | 26.94 | | 29.36 |
| Current year | 26.94 | | 28.6 |
| 1 year | 26.94 | | 44.6 |
| 3 years | 26.94 | | 71.8 |
| 5 years | 20.02 | | 71.8 |
| 10 years | 12.5 | | 71.8 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 55 | 24/01/1996 | |
| Director of Finance/CFO | - | 28/06/2018 | |
| Chief Operating Officer | 50 | 01/11/2008 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 73 | 22/06/2022 | |
| Director/Board Member | 55 | 22/06/2019 | |
| Director/Board Member | 50 | 01/11/2008 |
| Name | Varia. Jan 1. | Weight | AuM | |
|---|---|---|---|---|
 | +4.72% | 0.01% | 51 M€ |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -1.46% | +0.07% | -35.20% | -37.89% | 1.17B | |
| 0.00% | -1.05% | +19.01% | +41.54% | 18.43B | |
| -1.01% | +4.09% | -7.50% | -54.83% | 15.62B | |
| -0.53% | -2.35% | +8.43% | +67.74% | 11.58B | |
| -0.16% | -0.45% | +33.02% | +80.23% | 10.21B | |
| -0.08% | -5.78% | +7.69% | +64.24% | 10.08B | |
| +2.27% | -7.69% | -23.08% | -40.50% | 9.1B | |
| -0.40% | -3.89% | -31.58% | - | 7.5B | |
| +0.21% | -3.28% | +37.13% | +216.34% | 7.61B | |
| +0.22% | +3.25% | +6.38% | -45.11% | 5.65B | |
| Average | -0.09% | -1.81% | +1.43% | +32.42% | 9.7B | |
| Weighted average by Cap. | -0.06% | -1.69% | +5.95% | +35.09% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 1.22B 325M 279M 260M 242M 451M 29.33B 486M 2.98B 1.17B 14.03B 1.19B 51.41B | 1.37B 366M 314M 293M 272M 508M 33.08B 548M 3.37B 1.32B 15.82B 1.35B 57.98B |
| Net income | 252M 67.19M 57.66M 53.68M 49.96M 93.23M 6.07B 101M 617M 243M 2.9B 247M 10.63B | 308M 82.19M 70.53M 65.67M 61.11M 114M 7.42B 123M 755M 297M 3.55B 302M 13.01B |
| Net Debt | - | 398 106.12 91.06 84.79 78.9 147.24 9.58K 158.73 974.81 383.49 4.58K 389.8 16.79K |
| Date | Price | Change | Volume |
|---|---|---|---|
| 15/01/26 | 27.00 ﷼ | -1.46% | 66,560 |
| 14/01/26 | 27.40 ﷼ | -0.29% | 478,362 |
| 13/01/26 | 27.48 ﷼ | +0.51% | 312,134 |
| 12/01/26 | 27.34 ﷼ | +1.33% | 642,278 |
| 11/01/26 | 26.98 ﷼ | -0.07% | 590,994 |
Delayed Quote Saudi Arabian S.E., January 15, 2026 at 10:39 am
More quotes
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- 4007 Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition